Categories: Science

Ketamine use on the rise in U.S. adults; new trends emerge


A recent study analyzing data from the National Survey on Drug Use and Health (NSDUH) found that past-year recreational ketamine use among adults has increased dramatically since 2015, including significant shifts in associations with depression and sociodemographic characteristics such as race, age and education status. Ketamine use has shown promise in clinical trials therapy for several mental illnesses, including treatment-resistant depression, and the new research suggests that ongoing monitoring of recreational use trends is crucial to balancing these clinical benefits against the risk of unmonitored recreational use.

Key findings include:

  • Overall past-year recreational ketamine use increased by 81.8% from 2015 to 2019 and by 40% from 2021 to 2022.
  • Adults with depression were 80% more likely to have used ketamine in the past year in 2015-2019, but this association weakened in later years. In 2021-2022, ketamine use increased only among those without depression.
  • In 2021-2022, adults aged 26-34 were 66% more likely to have used ketamine in the past year compared to adults aged 18-25. Those with college degrees were more than twice as likely to have used ketamine compared to people with a high school education or less.
  • People were more likely to use ketamine if they used other substances, such as ecstasy/MDMA, GHB, and cocaine.

The researchers recommend expanding prevention outreach to settings like colleges, where younger adults may be at heightened risk, as well as providing education on the harms of polydrug use, particularly in combination with opioids. As medical ketamine becomes more widely available, they also emphasize the need for continued surveillance of recreational ketamine use patterns and further research to understand the factors that contribute to ketamine use.

The study, published online in the Journal of Affective Disorders, was led by Kevin Yang, M.D., a third-year resident physician in the Department of Psychiatry at UC San Diego School of Medicine. The research was supported by the National Institute on Drug Abuse of the National Institutes of Health.



Source link

24timenews.com

Recent Posts

Ihcl charts next growth phase with organisational revamp and senior leadership changes, ETTravelWorld

Indian Hotels Company (IHCL) has unveiled a major organisational redesign as part of its Accelerate…

4 hours ago

Toyota Is Already Testing A Hotter GR GT Supercar

Toyota is testing a track-focused, street-legal GR GT in Germany. The wild prototype has a…

4 hours ago

Scientists finally solved how a common gut bacterium triggers colon cancer

Scientists have uncovered how a toxin produced by a common gut bacterium gains access to…

4 hours ago

Ryan Garcia vs. Conor Benn set for September in Las Vegas under Zuffa Boxing banner

Ryan Garcia finally has a dance partner for his first world title defense. Garcia will…

14 hours ago

Why Did BMW Build The M2 AWD? For Americans

BMW built the M2 xDrive because of American and Swiss demand. Customers wanted an AWD…

14 hours ago

The hidden skeleton “gatekeeper” inside brain cells could help fight Alzheimer’s

Brain cells continually pull material from the fluid around them, including nutrients, signaling molecules, and…

14 hours ago